Logo image of CLBT

CELLEBRITE DI LTD (CLBT) Stock Fundamental Analysis

NASDAQ:CLBT - Nasdaq - IL0011794802 - Common Stock - Currency: USD

14.26  +0.06 (+0.42%)

After market: 14.22 -0.04 (-0.28%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to CLBT. CLBT was compared to 282 industry peers in the Software industry. CLBT has an excellent financial health rating, but there are some minor concerns on its profitability. CLBT has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

In the past year CLBT was profitable.
CLBT had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CLBT reported negative net income in multiple years.
CLBT had a positive operating cash flow in each of the past 5 years.
CLBT Yearly Net Income VS EBIT VS OCF VS FCFCLBT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 100M -100M -200M

1.2 Ratios

CLBT has a Return On Assets of -27.36%. This is in the lower half of the industry: CLBT underperforms 72.34% of its industry peers.
With a Return On Equity value of -53.44%, CLBT is not doing good in the industry: 68.44% of the companies in the same industry are doing better.
With an excellent Return On Invested Capital value of 11.22%, CLBT belongs to the best of the industry, outperforming 87.94% of the companies in the same industry.
CLBT had an Average Return On Invested Capital over the past 3 years of 7.06%. This is significantly below the industry average of 12.17%.
The last Return On Invested Capital (11.22%) for CLBT is above the 3 year average (7.06%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -27.36%
ROE -53.44%
ROIC 11.22%
ROA(3y)-9.14%
ROA(5y)-1.85%
ROE(3y)-54.72%
ROE(5y)N/A
ROIC(3y)7.06%
ROIC(5y)7.59%
CLBT Yearly ROA, ROE, ROICCLBT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 100 -100 -200

1.3 Margins

The Operating Margin of CLBT (14.30%) is better than 81.56% of its industry peers.
In the last couple of years the Operating Margin of CLBT has grown nicely.
With an excellent Gross Margin value of 84.06%, CLBT belongs to the best of the industry, outperforming 92.55% of the companies in the same industry.
In the last couple of years the Gross Margin of CLBT has remained more or less at the same level.
Industry RankSector Rank
OM 14.3%
PM (TTM) N/A
GM 84.06%
OM growth 3Y10.9%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.66%
GM growth 5Y1.3%
CLBT Yearly Profit, Operating, Gross MarginsCLBT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

7

2. Health

2.1 Basic Checks

CLBT has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, CLBT has more shares outstanding
CLBT has more shares outstanding than it did 5 years ago.
CLBT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CLBT Yearly Shares OutstandingCLBT Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
CLBT Yearly Total Debt VS Total AssetsCLBT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

An Altman-Z score of 6.87 indicates that CLBT is not in any danger for bankruptcy at the moment.
CLBT has a Altman-Z score of 6.87. This is in the better half of the industry: CLBT outperforms 75.89% of its industry peers.
CLBT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 6.87
ROIC/WACC1.17
WACC9.57%
CLBT Yearly LT Debt VS Equity VS FCFCLBT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 1.82 indicates that CLBT should not have too much problems paying its short term obligations.
CLBT has a Current ratio (1.82) which is in line with its industry peers.
A Quick Ratio of 1.79 indicates that CLBT should not have too much problems paying its short term obligations.
The Quick ratio of CLBT (1.79) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.82
Quick Ratio 1.79
CLBT Yearly Current Assets VS Current LiabilitesCLBT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

6

3. Growth

3.1 Past

CLBT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 27.91%, which is quite impressive.
The Revenue has grown by 22.05% in the past year. This is a very strong growth!
CLBT shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 18.47% yearly.
EPS 1Y (TTM)27.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25%
Revenue 1Y (TTM)22.05%
Revenue growth 3Y17.68%
Revenue growth 5Y18.47%
Sales Q2Q%20.06%

3.2 Future

CLBT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.52% yearly.
Based on estimates for the next years, CLBT will show a quite strong growth in Revenue. The Revenue will grow by 15.23% on average per year.
EPS Next Y11.44%
EPS Next 2Y10.76%
EPS Next 3Y14.31%
EPS Next 5Y12.52%
Revenue Next Year18.93%
Revenue Next 2Y18.12%
Revenue Next 3Y17.9%
Revenue Next 5Y15.23%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
CLBT Yearly Revenue VS EstimatesCLBT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M
CLBT Yearly EPS VS EstimatesCLBT Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0.2 0.4 0.6

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 32.41 indicates a quite expensive valuation of CLBT.
Based on the Price/Earnings ratio, CLBT is valued a bit cheaper than the industry average as 69.50% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 27.46, CLBT is valued at the same level.
With a Price/Forward Earnings ratio of 27.68, CLBT can be considered very expensive at the moment.
Based on the Price/Forward Earnings ratio, CLBT is valued a bit cheaper than the industry average as 67.38% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.44, CLBT is valued a bit cheaper.
Industry RankSector Rank
PE 32.41
Fwd PE 27.68
CLBT Price Earnings VS Forward Price EarningsCLBT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CLBT is valued a bit cheaper than 70.92% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CLBT is valued a bit cheaper than the industry average as 77.66% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 25.83
EV/EBITDA 37.91
CLBT Per share dataCLBT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CLBT does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as CLBT's earnings are expected to grow with 14.31% in the coming years.
PEG (NY)2.83
PEG (5Y)N/A
EPS Next 2Y10.76%
EPS Next 3Y14.31%

More info and screens

0

5. Dividend

5.1 Amount

CLBT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CELLEBRITE DI LTD

NASDAQ:CLBT (7/22/2025, 4:50:02 PM)

After market: 14.22 -0.04 (-0.28%)

14.26

+0.06 (+0.42%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-14 2025-05-14/bmo
Earnings (Next)08-14 2025-08-14/bmo
Inst Owners41.93%
Inst Owner Change-0.01%
Ins Owners2.71%
Ins Owner ChangeN/A
Market Cap3.41B
Analysts84.29
Price Target25.5 (78.82%)
Short Float %1.94%
Short Ratio1.54
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.43%
Min EPS beat(2)0.93%
Max EPS beat(2)15.93%
EPS beat(4)4
Avg EPS beat(4)40.28%
Min EPS beat(4)0.93%
Max EPS beat(4)86.74%
EPS beat(8)8
Avg EPS beat(8)63.98%
EPS beat(12)10
Avg EPS beat(12)43.82%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.92%
Min Revenue beat(2)-3.58%
Max Revenue beat(2)-0.26%
Revenue beat(4)2
Avg Revenue beat(4)0.31%
Min Revenue beat(4)-3.58%
Max Revenue beat(4)2.78%
Revenue beat(8)6
Avg Revenue beat(8)1.51%
Revenue beat(12)7
Avg Revenue beat(12)-0.3%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-10.18%
EPS NQ rev (1m)0%
EPS NQ rev (3m)9.94%
EPS NY rev (1m)0%
EPS NY rev (3m)10.23%
Revenue NQ rev (1m)-0.11%
Revenue NQ rev (3m)-2.71%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.9%
Valuation
Industry RankSector Rank
PE 32.41
Fwd PE 27.68
P/S 8.15
P/FCF 25.83
P/OCF 23.88
P/B 9.39
P/tB 10.54
EV/EBITDA 37.91
EPS(TTM)0.44
EY3.09%
EPS(NY)0.52
Fwd EY3.61%
FCF(TTM)0.55
FCFY3.87%
OCF(TTM)0.6
OCFY4.19%
SpS1.75
BVpS1.52
TBVpS1.35
PEG (NY)2.83
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -27.36%
ROE -53.44%
ROCE 14.2%
ROIC 11.22%
ROICexc 375.49%
ROICexgc N/A
OM 14.3%
PM (TTM) N/A
GM 84.06%
FCFM 31.53%
ROA(3y)-9.14%
ROA(5y)-1.85%
ROE(3y)-54.72%
ROE(5y)N/A
ROIC(3y)7.06%
ROIC(5y)7.59%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.94%
ROCE(5y)9.6%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y10.9%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.66%
GM growth 5Y1.3%
F-Score4
Asset Turnover0.59
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 102.56%
Cap/Sales 2.58%
Interest Coverage 250
Cash Conversion 202.89%
Profit Quality N/A
Current Ratio 1.82
Quick Ratio 1.79
Altman-Z 6.87
F-Score4
WACC9.57%
ROIC/WACC1.17
Cap/Depr(3y)92.67%
Cap/Depr(5y)99.76%
Cap/Sales(3y)2.81%
Cap/Sales(5y)2.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)27.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25%
EPS Next Y11.44%
EPS Next 2Y10.76%
EPS Next 3Y14.31%
EPS Next 5Y12.52%
Revenue 1Y (TTM)22.05%
Revenue growth 3Y17.68%
Revenue growth 5Y18.47%
Sales Q2Q%20.06%
Revenue Next Year18.93%
Revenue Next 2Y18.12%
Revenue Next 3Y17.9%
Revenue Next 5Y15.23%
EBIT growth 1Y41.52%
EBIT growth 3Y30.51%
EBIT growth 5YN/A
EBIT Next Year30.19%
EBIT Next 3Y22.99%
EBIT Next 5Y18.58%
FCF growth 1Y269.63%
FCF growth 3Y63.25%
FCF growth 5Y65.07%
OCF growth 1Y228%
OCF growth 3Y54.2%
OCF growth 5Y52.3%